We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Investors seeking momentum may have First Trust Health Care AlphaDEX ETF (FXH - Free Report) on radar now. The fund recently hit a new 52-week high. Shares of FXH are up approximately 50.3% from their 52-week low of $60.70/share.
But could there be more gains ahead for this ETF? Let’s take a look at the fund and the near-term outlook to get a better idea of where it might be headed.
FXH in Focus
The underlying StrataQuant Health Care Index employs the AlphaDEX stock selection methodology to select stocks from the Russell 1000 Index. FXH charges investors 62 basis points in fees per year (see all Healthcare ETFs here).
Why the move?
The healthcare sector has been performing well lately on rising vaccine hopes. The World Health Organization has recognised some 10 prime candidates for these potential coronavirus vaccines as these have entered clinical trials. Plus, 114 candidate vaccines are in preclinical evaluation stage.
More Gains Ahead?
Currently, FXH has a Zacks ETF Rank #3 (Hold) with a Medium risk outlook. So, it is difficult to get a handle on its future returns one way or another. The fund has a positive weighted alpha of 26.80. So, there is a decent outlook ahead.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Healthcare ETF (FXH) Hits New 52-Week High
Investors seeking momentum may have First Trust Health Care AlphaDEX ETF (FXH - Free Report) on radar now. The fund recently hit a new 52-week high. Shares of FXH are up approximately 50.3% from their 52-week low of $60.70/share.
But could there be more gains ahead for this ETF? Let’s take a look at the fund and the near-term outlook to get a better idea of where it might be headed.
FXH in Focus
The underlying StrataQuant Health Care Index employs the AlphaDEX stock selection methodology to select stocks from the Russell 1000 Index. FXH charges investors 62 basis points in fees per year (see all Healthcare ETFs here).
Why the move?
The healthcare sector has been performing well lately on rising vaccine hopes. The World Health Organization has recognised some 10 prime candidates for these potential coronavirus vaccines as these have entered clinical trials. Plus, 114 candidate vaccines are in preclinical evaluation stage.
More Gains Ahead?
Currently, FXH has a Zacks ETF Rank #3 (Hold) with a Medium risk outlook. So, it is difficult to get a handle on its future returns one way or another. The fund has a positive weighted alpha of 26.80. So, there is a decent outlook ahead.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>